Sort
10,766 grants matching “checkpoint inhibitor”
Regulation of DNA replication fork progression by ATM kinase activity
$266,401Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · CA
MECHANISMS FOR PITUITARY TUMORIGENESIS
$266,250Shlomo Melmed · Cedars-Sinai Medical Center · R01 · FY2008 · CA
MECHANISMS FOR PITUITARY TUMORIGENESIS
$266,250Shlomo Melmed · Cedars-Sinai Medical Center · R01 · FY2007 · CA
Project 2: Microenvironment Modification and Anti-PD1 Immunotherapy of Lymphoma
$266,083George J Weiner · University Of Iowa · P50 · FY2018 · CA
Project 3: BET bromodomain inhibitor combinations in breast cancer
$266,003Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2025 · CA
The Role of DRP-1 and Mitochondrial Fission in Pulmonary Arterial Hypertension
$265,950Stephen L Archer · Queen'S University At Kingston · R01 · FY2015 · HL
Immunophenotypic biomarkers to predict response and optimize immunotherapy-based combinations in breast cancer
$265,878Cesar Augusto Santa-Maria · Johns Hopkins University · K08 · FY2021 · CA
Immunophenotypic biomarkers to predict response and optimize immunotherapy-based combinations in breast cancer
$265,878Cesar Augusto Santa-Maria · Johns Hopkins University · K08 · FY2020 · CA
Immunophenotypic biomarkers to predict response and optimize immunotherapy-based combinations in breast cancer
$265,878Cesar Augusto Santa-Maria · Johns Hopkins University · K08 · FY2019 · CA
FUNCTION OF SGS1, A HOMOLOG OF BLM AND WRN
$265,860Columbia University Health Sciences · R01 · FY2000 · GM
Novel PTPRD interaction Controlling T cell Responsiveness
$265,500Michael Croft · La Jolla Institute For Immunology · R21 · FY2016 · AI
Suppression of translocations by RecQ-like DNA helicases
$264,600Kristina Schmidt · University Of South Florida · R01 · FY2008 · GM
Suppression of translocations by RecQ-like DNA helicases
$264,600Kristina Schmidt · University Of South Florida · R01 · FY2009 · GM
The Role of DRP-1 and Mitochondrial Fission in Pulmonary Arterial Hypertension
$264,600Stephen L Archer · Queen'S University At Kingston · R01 · FY2014 · HL
Quantitative High Throughput Screening for Small Molecules Targeting CD47 in Cancer
$264,598Thomas W Miller · Institut Jean Paoli & Irene Calmettes Centre Regional De Lutte Contre Le Cancer · R37 · FY2023 · CA
MECHANISMS OF DNA DAMAGE TRIGGERED S PHASE CHECKPOINTS
$264,485State University Of New York At Buffalo · R01 · FY2003 · CA
PDGF Regulation of Cell Growth and Death
$264,452Wayne State University · R01 · FY2004 · CA
PDGF Regulation of Cell Growth and Death
$264,429Wayne State University · R01 · FY2005 · CA
PDGF Regulation of Cell Growth and Death
$264,404Wayne State University · R01 · FY2003 · CA
Identifying Inhibitors of the APC/C Using Yeast Mutants
$264,328Daniel J Burke · University Of Virginia · R01 · FY2007 · CA
Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors
$264,066James F Kronauge · Cytosite Biopharma, Inc. · R44 · FY2018 · CA
Project 3 - Targeting CDK4/6 to modulate immunogenicity in gliomas (Wen/Zhao)
$264,010Jean Zhao · Brigham And Women'S Hospital · P50 · FY2020 · CA
SPORE: Targeted Therapies for Glioma - Diversity Supplement
$264,010Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2020 · CA
Function of TCF-1 in antagonizing malignancy
$264,000Zuoming Sun · Beckman Research Institute/City Of Hope · R21 · FY2022 · AI
MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7
$263,958Harvard University (Medical School) · R01 · FY2003 · CA